| 标题 |
Isatuximab plus carfilzomib–dexamethasone versus carfilzomib–dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial |
| 网址 | |
| DOI |
10.1016/S2352-3026(24)00148-0
doi
|
| 其它 |
期刊:The Lancet Haematology 作者:Kwee Yong; T. John Martin; Meletios Α. Dimopoulos; Joseph Mıkhael; Marcelo Capra; et al 出版日期:2024-07-24 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)